South Nassau earned the accreditation with commendation following a rigorous on-site evaluation by an ACS CoC surveyor to confirm that South Nassau is in compliance and deserving of commendation in each of the ACS CoC’s seven standards (the corresponding comment next to each standard is from the CoC’s Accredited Cancer Program Performance Report for South Nassau Communities Hospital:
• Outcomes analysis (South Nassau presented an “excellent”
• Abstracting timeframe (100% of abstracts South Nassau reviewed were completed within six months);
• Meeting National Cancer Data Base quality criteria (data for 2007, 2008, and 2009 were submitted by South Nassau without error);
• Compliance with College of American Pathologists (CAP) guidelines (100% of reports filed by South Nassau were in CAP compliance and in synoptic format);
• Clinical trial accrual (South Nassau cited for excellent accrual of research patients);
• Cancer-related quality improvements (South Nassau far exceeds the requirement with meaningful improvements);
• Prevention and early detection (South Nassau offers numerous prevention and early detection programs to the communities it serves each year).
“This accreditation is a testament to our commitment to provide a cancer care program that combines an experienced team of oncologists and staff with leading-edge medical and cancer treatment technologies so that the residents of the communities we serve do not have to leave their neighborhood to access standard-setting cancer care,” said Richard Murphy, president and CEO of South Nassau.
“We feature a multi-disciplinary team of accomplished medical, radiation, and surgical oncologists. They work together and use advanced diagnostic, medical, radiation, and surgical oncology technologies and treatments to treat a wide range of cancers,” added Rajiv Datta, MD, medical director of the Gertrude & Louis Feil Cancer Center and chief of surgical oncology at South Nassau.
Since its inception in 1922, the Commission's goal has been to reduce the morbidity and mortality of cancer through education, standard setting and the monitoring of quality care. Beginning in the 1930's, the Commission established standards and a program of review and accreditation for cancer programs. Currently almost 1,500 facilities have gained accreditation of their cancer program. It is estimated that ACS CoC accredited programs annually diagnose and treat 80% of all new cancer cases. This statistic emphasizes the level of commitment to resources that Commission-accredited programs have made to the care of patients with cancer.
Treating approximately 1,500 patients annually, the Gertrude & Louis Feil Cancer Center has evolved into one of the Northeast corridor’s premiere providers of compassionate advanced cancer care. The center is the only one on Long Island that is equipped with three of the most advanced and effective technologies used to treat and eradicate cancer: the Varian Novalis Tx™, da Vinci® Surgical System and Gamma Knife® Perfexion. In addition to its Cancer Center in Valley Stream, NY, the Gertrude & Louis Feil Cancer Center incorporates the following specialty cancer care services:
• South Nassau’s GYN Oncology Department (Valley Stream)
• South Nassau’s Long Island Gamma Knife® Center (Oceanside)
• South Nassau’s Center for Prostate Health Program (Oceanside)
• South Nassau’s Center for Breast Health (Oceanside)
• South Nassau’s Center for Lung Health (Oceanside/Valley Stream)
• South Nassau’s Radiation Oncology Department (Oceanside and Valley Stream)
• South Nassau’s Surgical Oncology Department (Oceanside and Valley Stream)
• Complete Women’s Imaging Center (Oceanside)
• South Nassau’s PET/CT Service (Oceanside)
South Nassau Communities Hospital is one of the region’s largest hospitals, with 435 beds, more than 900 physicians and 3,000 employees. Located in Oceanside, NY, the hospital is an acute-care, not-for-profit teaching hospital that provides state-of-the-